Phase 1 trial of recombinant Modified Vaccinia Ankara (MVA) encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients

Epstein-Barr virus (EBV) is associated with several malignancies including nasopharyngeal carcinoma (NPC), a high incidence tumor in Chinese populations, in which tumor cells express the two EBV antigens EBNA1 and LMP2. Here we report the Phase I trial of a recombinant vaccinia virus, MVA-EL, which...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Res
Hoofdauteurs: Hui, Edwin P, Taylor, Graham S, Jia, Hui, Ma, Brigette BY, Chan, Stephen L, Ho, Rosalie, Wong, WL, Wilson, Steven, Johnson, Benjamin F, Edwards, Ceri, Stocken, Deborah D, Rickinson, Alan B, Steven, Neil M, Chan, Anthony TC
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2013
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6485495/
https://ncbi.nlm.nih.gov/pubmed/23348421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-12-2448
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items